PREOPERATIVE MARKING OF LOCAL RELAPSE OF METASTASES OF DIFFERENTIATED THYROID-CARCINOMA WITH I-131 - AN INTEGRATED THERAPEUTIC APPROACH

被引:0
|
作者
PILGRIM, S [1 ]
KIFFNER, E [1 ]
BAHRE, M [1 ]
RICHTER, E [1 ]
机构
[1] MED UNIV LUBECK,CHIRURG KLIN,LUBECK,GERMANY
关键词
DIFFERENTIATED THYROID CARCINOMA; PREOPERATIVE SCINTIGRAPHY; RADIOIODINE THERAPY; TUMOR RELAPSE; LYMPH NODE METASTASES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the treatment of differentiated thyroid carcinoma local tumor relapse or metastases to cervical lymph nodes represent a therapeutical challenge. Tumor localization after repeated surgery is difficult, since anatomic structures have been destroyed. Moreover, a sufficiently high radiation dose can not be delivered to the tumor in all cases. A therapeutical approach is presented which facilitates intrasurgical localization of malignant tissue and allows an instant assessment of the operation success. In nine patients with local relapse or lymph node metastases of differentiated thyroid carcinoma radioiodine was applied before surgery. All functioning metastases could be localized and in most cases removed entirely. Radioiodine activity necessary for complete tumor ablation was considerably diminished. Eight out of nine patients remained free from recurrent tumor up to 42 months after therapy in spite of advanced primary tumor stages.
引用
收藏
页码:227 / 231
页数:5
相关论文
共 50 条
  • [1] HOW SAFE FOR THE PATIENT IS I-131 THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA
    HAYNIE, TP
    VASSILOPOULOUSELLIN, R
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (01) : 27 - 28
  • [2] THYROGLOBULIN RADIOIMMUNOASSAY AND I-131 SCINTIGRAPHY IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    LINDEGAARD, MW
    PAUS, E
    HOIE, J
    KULLMAN, G
    STENWIG, AE
    ACTA CHIRURGICA SCANDINAVICA, 1988, 154 (02): : 141 - 145
  • [3] TREATMENT OF DIFFERENTIATED THYROID-CARCINOMA IN 7 DOGS UTILIZING I-131
    ADAMS, WH
    WALKER, MA
    DANIEL, GB
    PETERSEN, MG
    LEGENDRE, AM
    VETERINARY RADIOLOGY & ULTRASOUND, 1995, 36 (05) : 417 - 424
  • [4] EFFECTS OF I-131 ABLATION OF THYROID REMNANTS AND I-131-THERAPY OF METASTASES ON SERUM THYROGLOBULIN LEVELS IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    SANGUINETI, M
    RANDAZZO, M
    CANEVAROLLO, N
    BERTOLAZZI, L
    ZINO, V
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 188 - 189
  • [5] EFFECTS OF I-131 THERAPY IN THYROID-CARCINOMA - A DOSIMETRIC APPROACH
    BAKKERTERVOORT, MA
    HOEFNAGEL, CA
    MARCUSE, HR
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1983, 8 (12): : A10 - A10
  • [6] THE USES OF I-131 IN THE MANAGEMENT OF THYROID-CARCINOMA
    PLOWMAN, PN
    BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (715): : 734 - 734
  • [7] ASSESSMENT OF FEMALE FERTILITY AND CARCINOGENESIS AFTER I-131 THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA
    DOTTORINI, ME
    LOMUSCIO, G
    MAZZUCCHELLI, L
    VIGNATI, A
    COLOMBO, L
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (01) : 21 - 27
  • [8] COMPOSITION OF CIRCULATING IODOPROTEINS FOLLOWING THERAPEUTIC APPLICATION OF I-131 FOR THYROID-CARCINOMA
    BEDNAR, J
    NEMEC, J
    SOUTOROVA, M
    ROHLING, S
    RADIOCHEMICAL AND RADIOANALYTICAL LETTERS, 1980, 45 (06): : 377 - 386
  • [9] I-131 THERAPY IN DIFFERENTIATED THYROID-CARCINOMA - MD-ANDERSON-HOSPITAL EXPERIENCE
    MAHESHWARI, YK
    HILL, CS
    HAYNIE, TP
    HICKEY, RC
    SAMAAN, NA
    CANCER, 1981, 47 (04) : 664 - 671
  • [10] INCREASED UPTAKE OF I-131 IN METASTASES OF DIFFERENTIATED THYROID-CARCINOMA ASSOCIATED WITH LESS SEVERE HYPOTHYROIDISM FOLLOWING TOTAL THYROIDECTOMY
    KASAGI, K
    MIYAMOTO, S
    ENDO, K
    SASAYAMA, S
    TAKEUCHI, R
    HIDAKA, A
    IIDA, Y
    MISAKI, T
    HATABU, H
    KONISHI, J
    CANCER, 1993, 72 (06) : 1983 - 1990